insights_auto
Why is MVIR up २.३३%?
Dive Deeperchevron_right
MVIR:STO
Medivir AB
SEK १.४९
arrow_upward
+२.३३%(+०.०३४) 1D
अक्टोबर ९, १७:२९:४२ GMT+२ · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MVIR...
Open
SEK १.४७
High
SEK १.५०
Low
SEK १.४५
Mkt. cap
९३.२५ करोड
Avg. vol.
१४.१३ लाख
Volume
१७.३२ लाख
52-wk high
SEK २.८८
52-wk low
SEK ०.३४
EPS
-SEK ०.३७
Shares outstanding
६२.४२ करोड
No. of employees
६
Open
SEK १.४७
High
SEK १.५०
Low
SEK १.४५
Mkt. cap
९३.२५ करोड
Avg. vol.
१४.१३ लाख
Volume
१७.३२ लाख
52-wk high
SEK २.८८
52-wk low
SEK ०.३४
EPS
-SEK ०.३७
Shares outstanding
६२.४२ करोड
No. of employees
६
News stories
From web sources and news partners
Simply Wall Street
·
५ मिनेट पहिले
Alnylam Pharmaceuticals (ALNY) Could Be 37% Undervalued After TTR Sales Probe
Crypto News
·
२२ मिनेट पहिले
Evernorth completes merger with 473m XRP ahead of Nasdaq debut
MarketBeat
·
३३ मिनेट पहिले
ITG Inc. (NASDAQ:ITG) Stock Has Average Target Price of $17.22
Yahoo Finance
·
२ घण्टा पहिले
Why “VOO and Chill” Lost Money for 8 Straight Years: What $100,000 in the S&P 500 Did From 2000 to 2008
Profile
Medivir is a Swedish biotech company. Medivir focuses its research focus on oncology and particularly on innovative pharmaceuticals that meet substantial unmet medical needs. The pharmaceutical development work is conducted both in-house and through partnerships, usually with global pharmaceutical companies.
Medivir has a leading expertise in the design of protease inhibitors and in the science of nucleotides and nucleosides.
Medivir is listed on the Nasdaq Stockholm Mid Cap List.
In February 2020, Medivir announced that the company has signed a licensing agreement for Xerclear with Chinese company Shijiazhuang Yuanmai Biotechnology Co Ltd. The agreement gives SYB the right to register, manufacture and market the product in China. Wikipedia
About Medivir AB